A phase I trial of inhaled iloprost for the prevention of lung cancer in former smokers
Ended Awarded Last action
- Contract number
- HHSN26100004
- Awardee
-
Northwestern University UEI KG76WYENL5K1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $826,870
Award facts
- Opportunity
-
- TORFPI Solicitation number
- Contract value 100% obligated
- $826,870.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Evanston, IL 60208, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | -$133,728 | |
| Other Administrative Action | $0 | |
| Funding Only Action | -$97,267 | |
| Exercise an Option | $447,364 | |
| Supplemental Agreement for work within scope | $65,493 | |
| Original award | $545,008 |
About this award
This federal contract award, with a ceiling value of $826,870.34, was issued by the National Cancer Institute (NCI) to Northwestern University for a Phase I clinical trial of inhaled iloprost to prevent lung cancer in former smokers. The award is part of the NCI's Cancer Prevention Agent Development Program, which supports early-phase research to evaluate novel cancer prevention agents.
Northwestern University, a private research university, is serving as the prime contractor for this work. The university has subcontracted portions of the study to the University of Colorado-Denver and National Jewish Health, both of which have extensive experience in respiratory and medical research. The contract does not have any set-aside designations.
Quick answers
Who was awarded contract HHSN26100004?
HHSN26100004 was awarded to Northwestern University by National Cancer Institute (National Institutes of Health) on August 26, 2014.
How much is contract HHSN26100004 worth?
The government has obligated $826,870 on HHSN26100004.
Is contract HHSN26100004 an order under another contract?
Yes. HHSN26100004 is a delivery order under HHSN261201200035I, an indefinite delivery contract, on Cancer Prevention Agent Development Program 2012-2017.
Was contract HHSN26100004 competed?
The extent of competition for HHSN26100004 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award